Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zheila J Azartash-Namin"'
Autor:
Yen-Chun Ho, Xin Geng, Anna O’Donnell, Jaime Ibarrola, Amaya Fernandez-Celis, Rohan Varshney, Kumar Subramani, Zheila J Azartash-Namin, Jang Kim, Robert Silasi, Jill Wylie-Sears, Zahra Alvandi, Lijuan Chen, Boksik Cha, Hong Chen, Lijun Xia, Bin Zhou, Florea Lupu, Harold M. Burkhart, Elena Aikawa, Lorin E. Olson, Jasimuddin Ahamed, Natalia López-Andrés, Joyce Bischoff, Katherine E. Yutzey, R. Sathish Srinivasan
BackgroundCardiac valve disease (CVD) is observed in 2.5% of the general population and 10% of the elderly people. Effective pharmacological treatments are currently not available, and patients with severe CVD require surgery. PROX1 and FOXC2 are tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d000032a201a79dafca023fa1d5d56fc
https://doi.org/10.1101/2023.05.10.540284
https://doi.org/10.1101/2023.05.10.540284
Publikováno v:
ASAIO Journal. 65:481-488
Gastrointestinal bleeding occurs in 20-30% of patients receiving ventricular assist devices (VADs) due, in part, to acquired von Willebrand syndrome. We examined factors to optimize a benchtop method to quantify changes in von Willebrand Factor (VWF)